| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Mar 4, 2025 | AbbVie Inc. | CEO | Sell | 16.3 | -27,186 | -16.99% | ✗ | $5.6M |
| Feb 28, 2024 | Mar 1, 2024 | AbbVie Inc. | COO | Sell | 15.0 | -106,517 | -21.43% | ✗ | $18.9M |
| Feb 28, 2023 | Mar 2, 2023 | AbbVie Inc. | Chair | Sell | 16.3 | -48,335 | -32.89% | ✗ | $7.5M |
| Feb 25, 2022 | Mar 1, 2022 | AbbVie Inc. | Chair | Sell | 2.5 | -77,391 | -67.14% | ✓ | $11.5M |
| Feb 28, 2021 | Mar 2, 2021 | AbbVie Inc. | CFO | Sell | 17.5 | -14,006 | -27.00% | ✗ | $1.5M |
| Feb 28, 2020 | Mar 3, 2020 | AbbVie Inc. | CFO | Sell | 20.0 | -7,438 | -26.84% | ✗ | $635.4K |
| Feb 28, 2019 | Mar 4, 2019 | AbbVie Inc. | CFO | Sell | 20.0 | -3,206 | -22.71% | ✗ | $254.6K |
| Feb 28, 2018 | Mar 2, 2018 | AbbVie Inc. | VP, Controller | Sell | 7.5 | -6,681 | -49.28% | ✓ | $795.1K |
| Feb 19, 2018 | Feb 20, 2018 | AbbVie Inc. | VP, Controller | Sell | 25.0 | -1,830 | -11.89% | ✓ | $218.7K |
| Sep 28, 2017 | Sep 29, 2017 | AbbVie Inc. | VP, Controller | Sell | 7.5 | -6,699 | -40.10% | ✓ | $589.5K |
| Mar 10, 2017 | Mar 10, 2017 | AbbVie Inc. | VP, Controller | Sell | 12.5 | -5,132 | -23.50% | ✓ | $335.1K |